AI assistance in tumor treatment meetings
Part of Cancer, Digestive system, Lungs & breathing, Skin clinical trials.
This study tests whether a large language model can help doctors make better decisions in tumor multidisciplinary team meetings. It evaluates junior doctors with specific experience levels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a junior doctor with a practice license.
- You are an oncologist, surgeon, radiation oncologist, radiologist, or pathologist with 3 to 5 years of experience.
- You are between 25 and 33 years old.
- You can commit to at least 10 hours during the study.
- You have not been involved in treating any of the 20 cases used in this research.
- You agree to join and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether an AI tool can help doctors read chest CT scans more accurately across the entire lung cancer care process. If you are a doctor who reads chest CT scans, you may be able to join and help improve cancer detection.
This study looks at whether artificial intelligence (AI) can make treatment decisions for colorectal cancer as well as a team of doctors. It uses past patient records to compare, so it doesn't involve new treatments or extra tests for patients.
This study tests whether a computer-based tool can help doctors make treatment decisions for stomach, colon, or rectal cancer. It compares the computer's suggestions with the recommendations of a team of cancer specialists.
This study tests an artificial intelligence (AI) system that uses your health information and medical images to better judge cancer risk and support diagnosis and treatment decisions. It may help doctors make more consistent assessments by combining clinical records, imaging, and other lab-style data.
This trial tests if an AI-powered system can help monitor and manage side effects during chemotherapy for breast or colorectal cancer. If you are starting chemotherapy and can report your symptoms, this study may offer extra support.
This study is testing a new way to use medical images, records, and other information to better assess cancer risk and guide treatment. It may be a good fit if you have a suspicious spot in your lungs, stomach, or colon, or if you are healthy and want to help with early cancer detection research.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.